olaparib

olaparib (LYNPARZA) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca. Route of administration: oral. Current US regulatory status: approved.

LYNPARZA is a marketed brand name for olaparib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

olaparib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.